| Nanocarrier-mediated chemo-immunotherapy arrested cancer progression and induced tumor dormancy in desmoplastic melanoma Q Liu, F Chen, L Hou, L Shen, X Zhang, D Wang, L Huang ACS nano 12 (8), 7812-7825, 2018 | 157 | 2018 |
| Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics F Chen, M Alphonse, Q Liu Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 12 (3 …, 2020 | 150 | 2020 |
| Nanoparticle-mediated trapping of Wnt family member 5A in tumor microenvironments enhances immunotherapy for B-Raf proto-oncogene mutant melanoma Q Liu, H Zhu, K Tiruthani, L Shen, F Chen, K Gao, X Zhang, L Hou, ... Acs Nano 12 (2), 1250-1261, 2018 | 91 | 2018 |
| Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma L Hou, Q Liu, L Shen, Y Liu, X Zhang, F Chen, L Huang Theranostics 8 (14), 3781, 2018 | 87 | 2018 |
| Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles for enhanced delivery and antitumor efficacy of paclitaxel J Zhang, R Chen, X Fang, F Chen, Y Wang, M Chen Nano Research 8, 201-218, 2015 | 82 | 2015 |
| Tumor pH e-triggered charge-reversal and redox-responsive nanoparticles for docetaxel delivery in hepatocellular carcinoma treatment F Chen, J Zhang, L Wang, Y Wang, M Chen Nanoscale 7 (38), 15763-15779, 2015 | 81 | 2015 |
| Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA F Chen, J Zhang, Y He, X Fang, Y Wang, M Chen Biomaterials science 4 (1), 167-182, 2016 | 76 | 2016 |
| Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles L Zou, F Chen, J Bao, S Wang, L Wang, M Chen, C He, Y Wang Drug delivery 23 (3), 898-906, 2016 | 41 | 2016 |
| Activated charge-reversal polymeric nano-system: The promising strategy in drug delivery for cancer therapy Y Hu, X Gong, J Zhang, F Chen, C Fu, P Li, L Zou, G Zhao Polymers 8 (4), 99, 2016 | 39 | 2016 |
| Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers F Chen, J Zhang, X Fang, H Yu, Y Liu, H Li, Y Wang, M Chen Acta Pharmacologica Sinica 38 (6), 859-873, 2017 | 32 | 2017 |
| Current strategies and potential prospects of nanomedicine-mediated therapy in inflammatory bowel disease F Chen, Q Liu, Y Xiong, L Xu International journal of nanomedicine, 4225-4237, 2021 | 31 | 2021 |
| Brain innate immune response via miRNA-TLR7 sensing in polymicrobial sepsis L Zou, J He, L Gu, RA Shahror, Y Li, T Cao, S Wang, J Zhu, H Huang, ... Brain, behavior, and immunity 100, 10-24, 2022 | 30 | 2022 |
| Targeting toll-like receptors in sepsis: from bench to clinical trials F Chen, L Zou, B Williams, W Chao Antioxidants & Redox Signaling 35 (15), 1324-1339, 2021 | 29 | 2021 |
| Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles: A dual-functional strategy for paclitaxel delivery. J Zhang, R Chen, F Chen, M Chen, Y Wang Journal of controlled release: official journal of the Controlled Release …, 2015 | 28 | 2015 |
| Role of extracellular microRNA-146a-5p in host innate immunity and bacterial sepsis S Wang, Y Yang, A Suen, J Zhu, B Williams, J Hu, F Chen, R Kozar, ... IScience 24 (12), 2021 | 21 | 2021 |
| Targeting mutant KRAS for anticancer therapy F Chen, MP Alphonse, Y Liu, Q Liu Current topics in medicinal chemistry 19 (23), 2098-2113, 2019 | 19 | 2019 |
| Pyruvate-driven oxidative phosphorylation is downregulated in sepsis-induced cardiomyopathy: a study of mitochondrial proteome BK Shimada, L Boyman, W Huang, J Zhu, Y Yang, F Chen, MA Kane, ... Shock 57 (4), 553-564, 2022 | 18 | 2022 |
| Targeting innate immunity in breast cancer therapy: a narrative review Y Ye, C Xu, F Chen, Q Liu, N Cheng Frontiers in Immunology 12, 771201, 2021 | 17 | 2021 |
| Uncovering the cellular capacity for intensive and specific feedback self-control of the argonautes and MicroRNA targeting activity D Wang, T Wang, A Gill, T Hilliard, F Chen, AL Karamyshev, F Zhang Nucleic acids research 48 (9), 4681-4697, 2020 | 15 | 2020 |
| Nanoparticle-based drug delivery systems for targeted epigenetics cancer therapy F Chen, Y Shi, J Zhang, Q Liu Current drug targets 21 (11), 1084-1098, 2020 | 14 | 2020 |
